Ahrens T N, Sramek J J, Herrera J M, Jewett C M, Alcorn V E
Metropolitan State Hospital, Norwalk, CA 90650.
Drug Intell Clin Pharm. 1988 Mar;22(3):205-8. doi: 10.1177/106002808802200305.
An ongoing screening program using pharmacists to detect tardive dyskinesia (TD) was developed, and a pharmacy-based prevalence survey of TD in chronic hospitalized psychiatric patients was undertaken to determine the extent of abnormal involuntary movements. The results show that older patients and women in particular are at higher risk for developing abnormal movements. Higher doses of neuroleptics were used in non-TD patients, indicating a possible masking effect caused by these drugs. By using a standardized rating method such as the Abnormal Involuntary Movement Scale, pharmacists can and should be utilized in the surveillance of TD.
